ORPHAN SYNERGY EUROPE-PHARMA (EPA:OSE)

PRESS RELEASE

published on 08/29/2025 at 08:00, 7 months 5 days ago

OSE Immunotherapeutics Reaffirms its Strategic Priorities and Publishes Shareholder Q&A to Restore Information Ahead of AGM
OSE Immunotherapeutics reaffirms strategic priorities with comprehensive Q&A document ahead of AGM. Company focuses on Tedopi® and Lusvertikimab programs for value creation

Strategic Priorities OSE Immunotherapeutics Lusvertikimab Shareholder Q&A Tedopi®
BRIEF

published on 08/25/2025 at 07:05, 7 months 9 days ago

OSE Immunotherapeutics : Nouvelle Gouvernance et Objectifs Stratégiques

Stratégie Gouvernance Actionnaires Biotechnologie Tedopi Et Lusvertikimab
BRIEF

published on 08/25/2025 at 07:05, 7 months 9 days ago

OSE Immunotherapeutics: New Governance and Strategic Objectives

Shareholders Biotechnology Governance Strategy Tedopi And Lusvertikimab
PRESS RELEASE

published on 08/25/2025 at 07:00, 7 months 9 days ago

OSE Immunotherapeutics Propose une Evolution de sa Gouvernance et Réaffirme ses Priorités Stratégiques à l’Approche de son Assemblée Générale Annuelle
OSE Immunotherapeutics propose une évolution de sa gouvernance et réaffirme ses priorités stratégiques. Assemblée Générale Annuelle le 30 septembre 2025 à Paris

Gouvernance Évolution Assemblée Générale Annuelle Priorités Stratégiques OSE Immunotherapeutics
PRESS RELEASE

published on 08/25/2025 at 07:00, 7 months 9 days ago

OSE Immunotherapeutics Proposes Governance Evolution and Reaffirms Strategic Priorities ahead of Annual General Meeting
OSE Immunotherapeutics announces proposed governance evolution and reaffirms strategic priorities ahead of Annual General Meeting. Company focuses on Tedopi® and Lusvertikimab to unlock full potential

Strategic Priorities Governance Evolution OSE Immunotherapeutics Lusvertikimab Tedopi
BRIEF

published on 08/20/2025 at 18:05, 7 months 13 days ago

OSE Immunotherapeutics Appoints Thomas Gidoin as CFO

Chief Financial Officer Strategic Planning Biotech Financing OSE Immunotherapeutics Thomas Gidoin
BRIEF

published on 08/20/2025 at 18:05, 7 months 13 days ago

OSE Immunotherapeutics nomme Thomas Gidoin au poste de directeur financier

Directeur Financier Planification Stratégique OSE Immunotherapeutics Financement Des Biotechnologies Thomas Gidoin
PRESS RELEASE

published on 08/20/2025 at 18:00, 7 months 13 days ago

OSE Immunotherapeutics Appoints Thomas Gidoin as Chief Financial Officer
OSE Immunotherapeutics appoints Thomas Gidoin as Chief Financial Officer, bringing deep expertise in capital markets and financial strategy to the company. Gidoin succeeds Anne-Laure Autret-Cornet

Chief Financial Officer Capital Markets Financial Strategy OSE Immunotherapeutics Thomas Gidoin
PRESS RELEASE

published on 08/20/2025 at 18:00, 7 months 13 days ago

OSE Immunotherapeutics nomme Thomas Gidoin au poste de Directeur Financier
Nomination de Thomas Gidoin comme nouveau Directeur Financier chez OSE Immunotherapeutics. Il apporte 15 ans d'expertise internationale en finance et gouvernance

Biotechnologie Finance Directeur Financier OSE Immunotherapeutics Thomas Gidoin
BRIEF

published on 07/02/2025 at 08:05, 9 months 1 day ago

Mises à jour d'OSE Immunotherapeutics sur les procédures judiciaires

Transparence Assemblée Des Actionnaires OSE Immunotherapeutics Procédures Judiciaires Tribunal De Commerce De Nantes

Published on 04/02/2026 at 22:00, 18 hours 7 minutes ago

Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 21 hours 35 minutes ago

Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 1 day 1 hour ago

Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 1 day 1 hour ago

Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 1 day 1 hour ago

Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution

View all ACCESSWIRE

Published on 04/03/2026 at 14:40, 1 hour 26 minutes ago

Monport Launches Next-Generation UV Laser Engraver for Precision Marking Across Europe
Published on 04/03/2026 at 14:35, 1 hour 31 minutes ago

Monport Expands Laser Technology Portfolio with Mega S CO2 Laser and UV Laser Engravers
Published on 04/03/2026 at 14:05, 2 hours 1 minute ago

AIRSEEKERS Tron and Tron SE Series Now Available: Redefining "Real Mowing" with FlowCut™ Technology
Published on 04/03/2026 at 11:47, 4 hours 20 minutes ago

EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 31 mars 2026
Published on 04/03/2026 at 11:05, 5 hours 1 minute ago

Hoymiles Bolsters European Plug-in Solar & Storage Market with HiFlow & HiFlow Pro Microinverters

View all EQS

Published on 04/03/2026 at 15:36, 31 minutes ago

Voting rights
Published on 04/03/2026 at 15:36, 31 minutes ago

Droits de vote
Published on 04/03/2026 at 15:34, 32 minutes ago

Évolution mensuelle du 31 mars 2026
Published on 04/03/2026 at 15:30, 37 minutes ago

Mise à disposition du Document d’Enregistrement Universel 2025
Published on 04/03/2026 at 14:44, 1 hour 22 minutes ago

Déclaration mensuelle du nombre total de droits de vote et du nombre d’actions composant le capital

View all LES ECHOS COMFI WIRE

News